LONDON & CAMBRIDGE, England--(BUSINESS WIRE)--Origin Sciences Ltd, a medical technology company developing unique sampling devices and diagnostics for patients with gastrointestinal diseases, has initiated a study to validate its OriCol™ device for calprotectin testing. The study will compare calprotectin levels in stool and rectal mucus of patients with suspected or confirmed inflammatory bowel disease (IBD).
